Literature DB >> 17618045

Leptin synergistically enhances the anti-apoptotic and growth-promoting effects of acid in OE33 oesophageal adenocarcinoma cells in culture.

Ian L P Beales1, Olorunseun O Ogunwobi.   

Abstract

Obesity and gastro-oesophageal reflux are the main predisposing factors for oesophageal adenocarcinoma. We have examined the effects of transient acid exposure and leptin on OE33 oesophageal adenocarcinoma cells. Leptin and acid individually stimulated proliferation and inhibited apoptosis and the combination was synergistic. Leptin receptor protein levels were unchanged by acid exposure. The COX-2 inhibitor NS 398 blocked the effects of acid and leptin but while both acid and leptin individually significantly increased PGE2 production and COX-2 mRNA levels, the combination was not more effective than either stimulant alone. Leptin synergistically enhanced acid-stimulated EGFR and ERK phosphorylation but did not further increase JNK or p38 MAP kinase phosphorylation. Specific EGFR and ERK inhibitors reduced the effects of leptin and acid alone and in combination. The combination of increased circulating leptin levels in obesity and transient reflux of gastric acid may promote oesophageal carcinogenesis by increasing proliferation and inhibiting apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618045     DOI: 10.1016/j.mce.2007.05.017

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  20 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction.

Authors:  Olivia M Thompson; Shirley A A Beresford; Elizabeth A Kirk; Mary P Bronner; Thomas L Vaughan
Journal:  Obesity (Silver Spring)       Date:  2010-01-28       Impact factor: 5.002

3.  Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus.

Authors:  Joel H Rubenstein; Hal Morgenstern; Daniel McConell; James M Scheiman; Philip Schoenfeld; Henry Appelman; Laurence F McMahon; John Y Kao; Val Metko; Min Zhang; John M Inadomi
Journal:  Gastroenterology       Date:  2013-08-30       Impact factor: 22.682

4.  Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study.

Authors:  Jose M Garcia; Andres E Splenser; Jennifer Kramer; Abeer Alsarraj; Stephanie Fitzgerald; David Ramsey; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-15       Impact factor: 11.382

Review 5.  Association of Serum Levels of Adipokines and Insulin With Risk of Barrett's Esophagus: A Systematic Review and Meta-Analysis.

Authors:  Apoorva Krishna Chandar; Swapna Devanna; Chang Lu; Siddharth Singh; Katarina Greer; Amitabh Chak; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

6.  Targeting key signalling pathways in oesophageal adenocarcinoma: a reality for personalised medicine?

Authors:  Richard R Keld; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

Review 7.  Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis.

Authors:  Shahab Uddin; Azhar R Hussain; Omar S Khan; Khawla S Al-Kuraya
Journal:  Tumour Biol       Date:  2013-09-07

8.  Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus.

Authors:  Stuart J Thomas; Lucy Almers; Jennifer Schneider; James E Graham; Peter J Havel; Douglas A Corley
Journal:  Dig Dis Sci       Date:  2015-09-22       Impact factor: 3.199

Review 9.  Mechanisms of obesity-induced gastrointestinal neoplasia.

Authors:  José O Alemán; Peter R Holt; Leonardo H Eusebi; Luigi Ricciardiello; Kavish Patidar; Arun J Sanyal
Journal:  Gastroenterology       Date:  2013-12-06       Impact factor: 22.682

10.  Exercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus.

Authors:  Brooke M Winzer; Jennifer D Paratz; Marina M Reeves; David C Whiteman
Journal:  BMC Cancer       Date:  2010-06-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.